ES2555139T3 - Nuevo procedimiento para la preparación de Linezolid y sus nuevos intermedios - Google Patents

Nuevo procedimiento para la preparación de Linezolid y sus nuevos intermedios Download PDF

Info

Publication number
ES2555139T3
ES2555139T3 ES12716665.0T ES12716665T ES2555139T3 ES 2555139 T3 ES2555139 T3 ES 2555139T3 ES 12716665 T ES12716665 T ES 12716665T ES 2555139 T3 ES2555139 T3 ES 2555139T3
Authority
ES
Spain
Prior art keywords
formula
new
compound
linezolid
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12716665.0T
Other languages
English (en)
Inventor
Raghu Mitra ALLA
Ajay Kumar DUBEY
Aruna Kumari Sirigiri
Naga Karna Kumar MAREEDU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lee Pharma Ltd
Original Assignee
Lee Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45999927&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2555139(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lee Pharma Ltd filed Critical Lee Pharma Ltd
Application granted granted Critical
Publication of ES2555139T3 publication Critical patent/ES2555139T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D269/00—Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups C07D261/00 - C07D267/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un procedimiento para preparar (R)-3-(3-fluoro-4-morfolinofenil)-2-oxo-5-oxazolidinil-metanol**Fórmula** que comprende: a) hacer reaccionar un compuesto de fórmula IX **Fórmula** con R-epiclorhidrina para producir un compuesto de fórmula VIII **Fórmula** que es adicionalmente convertido en el compuesto clorometil-oxazolidinona de fórmula VII **Fórmula** b) hacer reaccionar un compuesto de fórmula VII con acetato de sodio para producir un compuesto de fórmula VI **Fórmula** c) hidrolizar el producto de la etapa (b) para formar el compuesto de hidroximetil-oxazolidinona de fórmula V **Fórmula**
ES12716665.0T 2011-02-24 2012-02-21 Nuevo procedimiento para la preparación de Linezolid y sus nuevos intermedios Active ES2555139T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2451CH2010 2011-02-24
INCH24512010 2011-02-24
PCT/IN2012/000121 WO2012114355A1 (en) 2011-02-24 2012-02-21 Novel process for preparation of linezolid and its novel intermediates

Publications (1)

Publication Number Publication Date
ES2555139T3 true ES2555139T3 (es) 2015-12-29

Family

ID=45999927

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12716665.0T Active ES2555139T3 (es) 2011-02-24 2012-02-21 Nuevo procedimiento para la preparación de Linezolid y sus nuevos intermedios

Country Status (10)

Country Link
US (1) US9376407B2 (es)
EP (1) EP2595968B1 (es)
CN (2) CN106279054A (es)
ES (1) ES2555139T3 (es)
HR (1) HRP20151315T1 (es)
HU (1) HUE027158T2 (es)
PL (1) PL2595968T3 (es)
PT (1) PT2595968E (es)
SI (1) SI2595968T1 (es)
WO (1) WO2012114355A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014045292A1 (en) * 2012-09-20 2014-03-27 Symed Labs Limited Improved process for the preparation of linezolid intermediate
CN103601695B (zh) * 2013-10-22 2015-12-09 上海泰坦科技股份有限公司 (s)-4-苄基-3-丙酰基-2-恶唑烷酮的制备方法
WO2016079757A2 (en) * 2014-11-19 2016-05-26 Symed Labs Limited Novel processes for preparing 5-hydroxymethyl-oxazolidin-2-one derivatives
CN106316988B (zh) * 2015-06-16 2018-07-24 重庆常捷医药有限公司 利奈唑胺注射液降解杂质的制备方法
RU2766082C9 (ru) * 2016-04-21 2022-02-22 Оптимус Драгс Пвт Лтд Улучшенный процесс получения линезолида
CN109824617A (zh) * 2019-02-13 2019-05-31 扬子江药业集团北京海燕药业有限公司 一种利奈唑胺杂质m1z1及其制备方法和用途
CN110194750A (zh) * 2019-06-19 2019-09-03 四川美大康华康药业有限公司 一种利奈唑胺的制备方法及精制方法
CN112409286B (zh) 2019-08-20 2022-08-05 杭州迪克科技有限公司 一种n-取代苯基-5-羟甲基-2-噁唑烷酮的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4128654A (en) 1978-02-10 1978-12-05 E. I. Du Pont De Nemours And Company 5-Halomethyl-3-phenyl-2-oxazolidinones
US4340606A (en) 1980-10-23 1982-07-20 E. I. Du Pont De Nemours And Company 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
PT892792E (pt) * 1996-04-11 2002-05-31 Upjohn Co Processo para a preparacao de oxazolidinonas
PL1737850T3 (pl) 2004-04-19 2008-02-29 Symed Labs Ltd Nowy sposób wytwarzania linezolidu i związków pokrewnych
WO2006008754A1 (en) 2004-07-20 2006-01-26 Symed Labs Limited Novel intermediates for linezolid and related compounds
WO2009063505A2 (en) 2007-10-08 2009-05-22 Usv Limited Process for preparation of (s) (n-[[3-[3-fluoro-4-(4-morpholinyl) hen l -2-oxo-5-oxazolidin l methyl]acetamide
EP2899185B1 (en) * 2010-04-30 2018-01-31 Indiana University Research and Technology Corporation Processes for preparing linezolid

Also Published As

Publication number Publication date
WO2012114355A1 (en) 2012-08-30
PL2595968T3 (pl) 2016-03-31
EP2595968A1 (en) 2013-05-29
US9376407B2 (en) 2016-06-28
HUE027158T2 (en) 2016-08-29
US20130324719A1 (en) 2013-12-05
EP2595968B1 (en) 2015-09-09
CN103391927A (zh) 2013-11-13
HRP20151315T1 (hr) 2016-01-01
CN106279054A (zh) 2017-01-04
SI2595968T1 (sl) 2016-01-29
PT2595968E (pt) 2015-12-31

Similar Documents

Publication Publication Date Title
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
MX350892B (es) Síntesis de compuesto antiviral.
EP2590649A4 (en) PROCESS FOR SYNTHESIS OF SUBSTITUTED MORPHINANES
MX2020010330A (es) Proceso para preparar un compuesto antiviral de formula i.
MX2013002461A (es) Compuestos y composiciones novedosos para la inhibición de nampt.
MX2013011257A (es) Proceso para la preparacion de dronedarona por n-butilacion.
IN2014MN01521A (es)
IN2014DN00144A (es)
EP2681204A4 (en) SYNTHESIS OF INTERMEDIATE PRODUCTS FOR TREPROSTINE PRODUCTION
MX357613B (es) Métodos para producir sales de viloxazina y polimorfos novedosos de las mismas.
GEP20125512B (en) Process for synthesis of agomelatin
NZ702935A (en) Process for making hydroxylated cyclopentylpyrimidine compounds
AR088018A1 (es) Proceso e intermediarios para preparar lapatinib
BR112015015035A2 (pt) processo integrado para produção de ácido acético
CL2011000296A1 (es) Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados.
CO6710902A2 (es) Inhibidores de oxadiazol de la producción de leucotrienos
MX342273B (es) Proceso para la preparacion de esteres de acido (5-fluoro-2-metil-3-quinolina-2-ilmetil-indol-1-il)-acetico.
BR112012013582A2 (pt) processo para síntese de intermediários úteis para a produção de compostos de indazol e azaindazol substituídos
IN2014MN00850A (es)
EP3604273A3 (en) Process for the synthesis of highly pure cationic surfactant products
AR077332A1 (es) Procesos para la alquilacion de pirazoles
AR098879A1 (es) Síntesis de ent-progesterona y sus productos intermedios
CO6700822A2 (es) Proceso para preparar 3-haloalquilporazoles
BR112013015532B1 (pt) ácido 2-(alcóxi ou ariloxicarbonil)-4-metil-6-(2,6,6-trimetilcicloex-1-enil)-hex-2-enoico, metódo para sua preparação e seus usos
MX2013004193A (es) Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico.